| Identification | Back Directory | [Name]
N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine 3’-CED phosphoramidite | [CAS]
2382942-35-8 | [Synonyms]
2’OC16-A(Bz) phosphoramidite
2'-O-C16-rA(Bz)-Phosphoramidite
2'-O-Hexadecyl-A(Bz)-CE-Phosphoramidite
DMTr-2'-O-C16-rA(Bz)-3'-CE
-Phosphoramidite
DMTr-2’-O-C16-rA(Bz)-3’-CE -Phosphoramidite
N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine 3’-CED phosphoramidite
N6 -Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine 3’-CED phosphoramidite | [Molecular Formula]
C63H84N7O8P | [MOL File]
2382942-35-8.mol | [Molecular Weight]
1098.38 |
| Hazard Information | Back Directory | [Uses]
N6-Bz-5’-O-DMTr-2’-O-hexadecanyl adenosine 3’-CED phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
HitGen Inc.
|
| Tel: |
028-028-85197385 13618381045 |
| Website: |
www.hitgen.com/ |
|